Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 9/20 | 0.70 |
| ▸ | ALDH1A1 | P00352 | 9/20 | 0.70 |
| ▸ | MEN1 | O00255 | 8/20 | 0.70 |
| ▸ | TDP1 | Q9NUW8 | 4/20 | 0.70 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.69 |
| ▸ | LMNA | P02545 | 4/20 | 0.65 |
| ▸ | RECQL | P46063 | 3/20 | 0.62 |
| ▸ | POLB | P06746 | 1/20 | 0.62 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.62 |
| ▸ | MAPT | P10636 | 4/20 | 0.59 |
| ▸ | PKM | P14618 | 1/20 | 0.59 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.59 |
| ▸ | GAA | P10253 | 1/20 | 0.59 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.59 |
| ▸ | HTT | P42858 | 1/20 | 0.58 |
| ▸ | RRM1 | P23921 | 1/20 | 0.58 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.57 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.57 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.57 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL714848 | 1.00 | KMT2A (0.70) | KMT2AALDH1A1MEN1TDP1KDM4E | |
| SCHEMBL6638949 | 1.00 | KMT2A (0.70) | KMT2AALDH1A1MEN1TDP1KDM4E | |
| SCHEMBL7001854 | 0.98 | KMT2A (0.68) | KMT2AALDH1A1MEN1TDP1KDM4E | |
| SCHEMBL7001853 | 0.98 | KMT2A (0.68) | KMT2AALDH1A1MEN1TDP1KDM4E | |
| SCHEMBL28665880 | 0.94 | KMT2A (0.71) | KMT2AALDH1A1MEN1TDP1KDM4E | |
| SCHEMBL28665881 | 0.94 | KMT2A (0.71) | KMT2AALDH1A1MEN1TDP1KDM4E | |
| SCHEMBL27596882 | 0.94 | KMT2A (0.72) | KMT2AALDH1A1MEN1TDP1KDM4E | |
| SCHEMBL18804653 | 0.94 | KMT2A (0.72) | KMT2AALDH1A1MEN1TDP1KDM4E | |
| Fluorobenzene SCHEMBL28187017 | 0.93 | KMT2A (0.72) | KMT2AALDH1A1MEN1TDP1KDM4E | |
| SCHEMBL25063711 | 0.92 | KMT2A (0.80) | KMT2AALDH1A1MEN1TDP1KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122039073-A | Preparation method of selenosulfonate derivative | 宁夏医科大学 | 2026-05-15 | — | — | CN | disclosed |
| EP-4605247-A1 | ELASTOMERIC COMPOSITIONS FOR TYRES COMPRISING NNEEWW CROSS-LINKING FUNCTIONALISING AGENTS, ELASTOMERIC COMPOUNDS AND TYRES COMPRISING THEM | Pirelli Tyre S.p.A. (IT) | 2025-08-27 | — | — | EP | disclosed |
| EP-3965738-B1 | METHOD FOR PRODUCTION OF LIPOSOMES | UNIV DO MINHO (PT) | 2025-08-06 | — | — | EP | disclosed |
| WO-2025136936-A1 | AGONISTS OF TREM2 ACTIVITY | MERCK SHARP & DOHME LLC (US) | 2025-06-26 | — | — | WO | disclosed |
| WO-2024084386-A9 | ELASTOMERIC COMPOSITIONS FOR TYRES COMPRISING NNEEWW CROSS-LINKING FUNCTIONALISING AGENTS, ELASTOMERIC COMPOUNDS AND TYRES COMPRISING THEM | PIRELLI TYRE S.P.A. (IT) | 2025-06-12 | — | — | WO | disclosed |
| US-20220241203-A1 | METHOD FOR PRODUCTION OF LIPOSOMES | UNIVERSIDADE DO MINHO (PT) | 2022-08-04 | — | — | US | disclosed |
| CN-113816906-A | Synthesis method of novel azepane | 成都理工大学 | 2021-12-21 | — | — | CN | disclosed |
| WO-2021012264-A1 | TRIAZOLE SULFONAMIDE DERIVATIVE, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF | 东莞市东阳光农药研发有限公司 | 2021-01-28 | — | — | WO | disclosed |
| WO-2017183043-A1 | NOVEL PROCESS FOR THE PREPARATION OF TAVABOROLE, ITS NOVEL POLYMORPHIC FORMS AND THE POLYMORPHS THEREOF | BIOPHORE INDIA PHARMACEUTICALS PVT. LTD. (IN) | 2017-10-26 | — | — | WO | disclosed |
| US-8124578-B2 | Use of dynamic mixtures for a controlled release of fragrances | FIRMENICH SA (CH) | 2012-02-28 | — | — | US | disclosed |
| EP-1478437-A1 | ACC INHIBITORS | Pfizer Products Inc. (US) | 2004-11-24 | — | — | EP | disclosed |
| US-20030187254-A1 | Acetyl-CoA carboxylase inhibitors | PFIZER INC. | 2003-10-02 | — | — | US | disclosed |
| WO-2003072197-A1 | ACC INHIBITORS | PFIZER PRODUCTS INC. (US) | 2003-09-04 | — | — | WO | disclosed |
| US-6313290-B1 | Azolobenzazepine derivatives and compositions and method of use thereof | ZENECA LIMITED (GB) | 2001-11-06 | — | — | US | disclosed |
| US-6124281-A | TREATING STROKES | ZENECA LIMITED (GB) | 2000-09-26 | — | — | US | disclosed |
| US-5994552-A | Process for the production of substituted thiazoline-dioxetan substrates and use thereof | ROCHE DIAGNOSTICS GMBH (DE) | 1999-11-30 | — | — | US | disclosed |
| EP-0888350-A1 | AZOLOBENZAZEPINE DERIVATIVES AS NEUROLOGICALLY ACTIVE AGENTS | ZENECA LIMITED (GB) | 1999-01-07 | — | — | EP | disclosed |
| US-5712106-A | Process for the production of substituted thiazolin-dioxetan substrates and use thereof | BOEHRINGER MANNHEIM GMBH (DE) | 1998-01-27 | — | — | US | disclosed |
| WO-1997032883-A1 | AZOLOBENZAZEPINE DERIVATIVES AS NEUROLOGICALLY ACTIVE AGENTS | ZENECA LIMITED (GB) | 1997-09-12 | — | — | WO | disclosed |
| US-5455357-A | Substituted thiazoline-dioxetan substrates, process for the production and use | BOEHRINGER MANNHEIM GMBH (DE) | 1995-10-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030187254-A1 | Acetyl-CoA carboxylase inhibitors | ACACA, ACACB, ACAT1 | KMT2A 2346/4885ALDH1A1 654/4885MEN1 3712/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.